| 25 May 2026 |
Tirzepatide |
5.7 |
30mg |
33.4mg |
+11.3% |
99.70% |
Lab G |
| 25 May 2026 |
ACE-031 |
7.9 |
20mg |
20.6mg |
+3.1% |
97.63% |
Lab F |
| 25 May 2026 |
BMK glycidic acid (free acid) CAS 25547-51-7 |
6.9 |
500g |
616.0g |
+23.2% |
95.66% |
Lab E |
| 25 May 2026 |
BMK glycidic acid (free acid) CAS 25547-51-7 |
7.1 |
500g |
457.1g |
-8.6% |
96.60% |
Lab D |
| 25 May 2026 |
Dianabol |
7.9 |
10mg |
10.0mg |
-0.5% |
96.87% |
Lab E |
| 25 May 2026 |
Lipo-C FAT BLASTER |
8.4 |
100mg/ml |
93.8mg/ml |
-6.2% |
99.52% |
Lab E |
| 25 May 2026 |
PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 |
7.8 |
5g |
6.2g |
+24.4% |
98.14% |
Lab E |
| 25 May 2026 |
Telmisartan |
9.8 |
100mg |
110.5mg |
+10.5% |
98.01% |
Lab G |
| 24 May 2026 |
ACE-031 |
5.5 |
20mg |
23.8mg |
+18.9% |
95.45% |
Lab D |
| 24 May 2026 |
BPC157 5mg + TB500 5mg Blend |
8.5 |
2mg |
1.9mg |
-6.2% |
97.86% |
Lab A |
| 24 May 2026 |
CJC-1295 With DAC |
4.5 |
5mg |
5.9mg |
+17.5% |
96.65% |
Lab A |
| 24 May 2026 |
CJC-1295 With DAC |
6.6 |
30mg |
28.8mg |
-3.9% |
98.14% |
Lab G |
| 24 May 2026 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
6.7 |
50mg |
60.1mg |
+20.1% |
99.60% |
Lab D |
| 24 May 2026 |
Dianabol |
5.1 |
100mg |
101.6mg |
+1.6% |
99.14% |
Lab A |
| 24 May 2026 |
Glutathione |
6.7 |
2mg |
1.9mg |
-4.9% |
96.17% |
Lab G |
| 24 May 2026 |
HGH Fragment 176-191 |
6.4 |
10mg |
8.8mg |
-12.3% |
97.31% |
Lab D |
| 24 May 2026 |
MOTS-C |
6.9 |
10mg |
10.8mg |
+8.5% |
96.51% |
Lab F |
| 24 May 2026 |
NAD+ Injectable |
6.3 |
200mg/ml |
199.7mg/ml |
-0.1% |
97.71% |
Lab F |
| 24 May 2026 |
NAD+ Injectable |
7.4 |
200mg/ml |
199.1mg/ml |
-0.4% |
95.25% |
Lab A |
| 24 May 2026 |
PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 |
4.9 |
5g |
5.7g |
+13.7% |
95.63% |
Lab D |
| 24 May 2026 |
Super Human Blend (Arginine+Ornithine+Citrulline+Lysine+Glutamine+Proline+Taurine+Carnitine+NAC) |
7.9 |
100mg/ml |
96.8mg/ml |
-3.2% |
97.55% |
Lab A |
| 24 May 2026 |
Telmisartan |
6.8 |
25mg |
23.4mg |
-6.4% |
96.25% |
Lab C |
| 24 May 2026 |
Tirzepatide |
3.3 |
30mg |
53.4mg |
+78.0% |
99.49% |
Lab E |
| 24 May 2026 |
Retatrutide |
8.0 |
30mg |
31.3mg |
+4.3% |
99.90% |
Lab G |
| 24 May 2026 |
Tirzepatide |
9.5 |
10mg |
9.9mg |
-1.0% |
99.70% |
Lab G |
| 24 May 2026 |
Tirzepatide |
9.8 |
30mg |
28.3mg |
-5.7% |
99.90% |
Lab G |
| 24 May 2026 |
Tirzepatide |
7.8 |
20mg |
20.5mg |
+2.5% |
99.80% |
Lab G |
| 24 May 2026 |
Tirzepatide |
7.2 |
90mg |
96.1mg |
+6.8% |
99.80% |
Lab G |
| 24 May 2026 |
BMK glycidic acid (free acid) CAS 25547-51-7 |
7.4 |
100g |
119.9g |
+19.9% |
97.66% |
Lab F |
| 24 May 2026 |
BPC157 5mg + TB500 5mg Blend |
5.2 |
5mg |
4.3mg |
-13.9% |
97.77% |
Lab D |
| 24 May 2026 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
7.7 |
30mg |
35.9mg |
+19.8% |
99.05% |
Lab F |
| 24 May 2026 |
Finasteride |
6.4 |
10mg |
9.3mg |
-7.1% |
95.10% |
Lab D |
| 24 May 2026 |
GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg |
5.8 |
50mg |
46.5mg |
-7.1% |
99.09% |
Lab G |
| 24 May 2026 |
Glutathione |
4.5 |
10mg |
12.2mg |
+22.4% |
99.36% |
Lab G |
| 24 May 2026 |
Methylene Blue |
7.6 |
25mg |
24.1mg |
-3.4% |
96.78% |
Lab G |
| 24 May 2026 |
MK-677 (Ibutamoren) Raw |
5.1 |
500g |
505.6g |
+1.1% |
99.13% |
Lab D |
| 24 May 2026 |
MK-677 (Ibutamoren) Raw |
6.1 |
5g |
4.7g |
-6.7% |
96.32% |
Lab E |
| 24 May 2026 |
NAD+ Injectable |
8.3 |
300mg/ml |
300.5mg/ml |
+0.2% |
98.87% |
Lab C |
| 24 May 2026 |
Ovagen |
6.4 |
2mg |
1.9mg |
-4.5% |
97.20% |
Lab C |
| 24 May 2026 |
Prostamax |
10.0 |
15mg |
18.2mg |
+21.5% |
97.47% |
Lab F |
| 24 May 2026 |
Prostamax |
6.7 |
50mg |
44.2mg |
-11.5% |
99.87% |
Lab D |
| 24 May 2026 |
Trestolone Acetate (MENT) Raw |
7.3 |
500g |
459.9g |
-8.0% |
96.22% |
Lab B |
| 24 May 2026 |
Vitamin B12 10mg/ml |
5.2 |
200mg/ml |
249.0mg/ml |
+24.5% |
97.28% |
Lab F |
| 24 May 2026 |
ACE-031 |
6.4 |
10mg |
11.1mg |
+11.4% |
97.56% |
Lab D |
| 24 May 2026 |
BMK glycidic acid (free acid) CAS 25547-51-7 |
6.3 |
5g |
5.9g |
+17.6% |
95.70% |
Lab A |
| 24 May 2026 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
5.9 |
5mg |
4.9mg |
-1.3% |
99.02% |
Lab B |
| 24 May 2026 |
Glutathione |
8.3 |
30mg |
28.2mg |
-6.2% |
96.57% |
Lab E |
| 24 May 2026 |
Halotestin (Fluoxymesterone) |
6.3 |
10mg |
8.8mg |
-11.9% |
97.64% |
Lab G |
| 24 May 2026 |
Methylene Blue |
7.4 |
10mg |
9.9mg |
-1.3% |
97.59% |
Lab A |
| 24 May 2026 |
Methylene Blue |
8.2 |
20mg |
19.8mg |
-0.8% |
98.05% |
Lab D |
| 24 May 2026 |
NAD+ Injectable |
6.9 |
300mg/ml |
335.3mg/ml |
+11.8% |
98.40% |
Lab E |
| 24 May 2026 |
P21 |
7.7 |
2mg |
1.8mg |
-12.1% |
95.31% |
Lab C |
| 24 May 2026 |
PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 |
7.5 |
10g |
12.3g |
+23.4% |
96.82% |
Lab B |
| 24 May 2026 |
BMK glycidic acid (free acid) CAS 25547-51-7 |
9.7 |
100g |
107.1g |
+7.1% |
97.59% |
Lab E |
| 24 May 2026 |
BMK glycidic acid (free acid) CAS 25547-51-7 |
4.6 |
100g |
105.0g |
+5.0% |
99.68% |
Lab C |
| 24 May 2026 |
CJC-1295 With DAC |
5.0 |
15mg |
17.3mg |
+15.1% |
95.09% |
Lab G |
| 24 May 2026 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
5.6 |
10mg |
9.9mg |
-0.8% |
96.45% |
Lab A |
| 24 May 2026 |
Finasteride |
9.9 |
20mg |
22.7mg |
+13.3% |
96.28% |
Lab C |
| 24 May 2026 |
MOTS-C |
7.4 |
10mg |
9.7mg |
-2.8% |
97.37% |
Lab B |
| 24 May 2026 |
NAD+ Injectable |
7.2 |
200mg/ml |
178.6mg/ml |
-10.7% |
96.72% |
Lab F |
| 24 May 2026 |
PE 22-28 |
8.7 |
50mg |
49.6mg |
-0.7% |
96.68% |
Lab E |
| 24 May 2026 |
Primobolan Oral (Methenolone Acetate) |
7.7 |
20mg |
24.4mg |
+21.8% |
95.31% |
Lab D |
| 24 May 2026 |
Turinabol Raw |
8.8 |
1g |
1.0g |
+1.1% |
99.08% |
Lab E |
| 24 May 2026 |
Turinabol Raw |
7.4 |
5g |
4.3g |
-14.3% |
97.30% |
Lab E |
| 24 May 2026 |
Vitamin B12 10mg/ml |
8.2 |
250mg/ml |
304.6mg/ml |
+21.8% |
99.49% |
Lab B |
| 24 May 2026 |
AICAR |
9.9 |
10mg |
12.5mg |
+25.0% |
97.16% |
Lab C |
| 24 May 2026 |
BPC157 10mg + TB500 10mg Blend |
5.4 |
30mg |
35.2mg |
+17.3% |
97.36% |
Lab D |
| 24 May 2026 |
Enclomiphene |
7.8 |
25mg |
29.3mg |
+17.3% |
96.02% |
Lab B |
| 24 May 2026 |
Finasteride |
5.6 |
25mg |
26.7mg |
+6.9% |
99.96% |
Lab E |
| 24 May 2026 |
Methylene Blue |
8.8 |
25mg |
21.5mg |
-14.0% |
97.97% |
Lab A |
| 24 May 2026 |
MOTS-C |
8.2 |
2mg |
2.1mg |
+2.5% |
97.58% |
Lab C |
| 24 May 2026 |
PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 |
4.2 |
500g |
482.5g |
-3.5% |
95.64% |
Lab E |
| 24 May 2026 |
Super Human Blend (Arginine+Ornithine+Citrulline+Lysine+Glutamine+Proline+Taurine+Carnitine+NAC) |
9.1 |
250mg/ml |
250.3mg/ml |
+0.1% |
96.24% |
Lab E |
| 24 May 2026 |
Vitamin B12 10mg/ml |
7.8 |
300mg/ml |
307.1mg/ml |
+2.4% |
95.47% |
Lab E |
| 23 May 2026 |
ACE-031 |
5.8 |
5mg |
4.6mg |
-7.2% |
99.80% |
Lab F |
| 23 May 2026 |
BMK glycidic acid (free acid) CAS 25547-51-7 |
5.4 |
100g |
122.7g |
+22.7% |
99.20% |
Lab B |
| 23 May 2026 |
BPC157 10mg + TB500 10mg Blend |
7.3 |
15mg |
13.2mg |
-12.2% |
96.28% |
Lab C |
| 23 May 2026 |
BPC157 10mg + TB500 10mg Blend |
7.7 |
5mg |
4.5mg |
-9.3% |
96.50% |
Lab B |
| 23 May 2026 |
BPC157 10mg + TB500 10mg Blend |
6.5 |
20mg |
23.2mg |
+15.9% |
96.54% |
Lab D |
| 23 May 2026 |
BPC157 10mg + TB500 10mg Blend |
8.7 |
50mg |
43.8mg |
-12.3% |
98.46% |
Lab F |
| 23 May 2026 |
BPC157 5mg + TB500 5mg Blend |
8.2 |
2mg |
2.2mg |
+8.0% |
95.04% |
Lab F |
| 23 May 2026 |
Dianabol |
7.9 |
10mg |
12.2mg |
+22.0% |
98.11% |
Lab A |
| 23 May 2026 |
Enclomiphene |
8.4 |
10mg |
10.6mg |
+6.3% |
99.11% |
Lab C |
| 23 May 2026 |
Enclomiphene |
8.7 |
20mg |
25.0mg |
+25.0% |
96.78% |
Lab F |
| 23 May 2026 |
Lipo-C FAT BLASTER |
6.7 |
250mg/ml |
249.1mg/ml |
-0.4% |
98.88% |
Lab E |
| 23 May 2026 |
MOTS-C |
7.6 |
50mg |
44.1mg |
-11.9% |
95.42% |
Lab F |
| 23 May 2026 |
P21 |
7.8 |
2mg |
2.3mg |
+15.9% |
97.02% |
Lab F |
| 23 May 2026 |
Telmisartan |
8.5 |
25mg |
25.0mg |
-0.2% |
99.01% |
Lab B |
| 23 May 2026 |
Telmisartan |
8.0 |
50mg |
48.3mg |
-3.4% |
95.27% |
Lab F |
| 23 May 2026 |
Thymosin Alpha-1 |
6.9 |
15mg |
12.8mg |
-14.9% |
96.06% |
Lab A |
| 23 May 2026 |
ACE-031 |
5.4 |
50mg |
56.2mg |
+12.4% |
99.66% |
Lab G |
| 23 May 2026 |
Enclomiphene |
9.2 |
25mg |
28.6mg |
+14.3% |
99.99% |
Lab F |
| 23 May 2026 |
Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) |
8.5 |
200mg/ml |
233.1mg/ml |
+16.5% |
98.50% |
Lab D |
| 23 May 2026 |
Lipo-C FAT BLASTER |
8.5 |
250mg/ml |
221.9mg/ml |
-11.2% |
99.58% |
Lab A |
| 23 May 2026 |
PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 |
7.3 |
5g |
5.8g |
+16.6% |
96.77% |
Lab C |
| 23 May 2026 |
Vitamin B12 10mg/ml |
7.1 |
100mg/ml |
108.2mg/ml |
+8.2% |
99.96% |
Lab A |
| 21 May 2026 |
ACE-031 |
8.1 |
15mg |
13.2mg |
-12.0% |
97.37% |
Lab C |
| 21 May 2026 |
AICAR |
9.6 |
15mg |
16.1mg |
+7.0% |
99.76% |
Lab A |
| 21 May 2026 |
Dianabol |
6.8 |
20mg |
22.4mg |
+12.1% |
95.72% |
Lab D |
| 21 May 2026 |
Finasteride |
6.6 |
20mg |
20.9mg |
+4.4% |
98.50% |
Lab A |
| 21 May 2026 |
Trestolone Acetate (MENT) Raw |
5.9 |
500g |
614.6g |
+22.9% |
96.83% |
Lab B |
| 21 May 2026 |
Winstrol Oil (Stanozolol) |
7.6 |
300mg/ml |
257.3mg/ml |
-14.2% |
96.65% |
Lab B |
| 21 May 2026 |
BPC157 5mg + TB500 5mg Blend |
8.9 |
30mg |
33.2mg |
+10.7% |
99.02% |
Lab E |
| 21 May 2026 |
CJC-1295 With DAC |
7.7 |
15mg |
17.1mg |
+14.1% |
97.26% |
Lab F |
| 21 May 2026 |
Glutathione |
6.6 |
15mg |
18.1mg |
+20.5% |
95.47% |
Lab G |
| 21 May 2026 |
Methylene Blue |
9.2 |
25mg |
28.0mg |
+12.1% |
97.69% |
Lab B |
| 21 May 2026 |
Ovagen |
6.1 |
2mg |
2.4mg |
+22.3% |
98.65% |
Lab D |
| 21 May 2026 |
SLU-PP-332 250mcg + BAM15 50mcg Blend |
9.4 |
100mg |
120.4mg |
+20.4% |
98.94% |
Lab E |
| 21 May 2026 |
Thymosin Alpha-1 |
5.2 |
20mg |
21.7mg |
+8.6% |
99.98% |
Lab C |
| 21 May 2026 |
Trestolone Acetate (MENT) Raw |
8.2 |
5g |
5.8g |
+15.0% |
97.35% |
Lab E |
| 21 May 2026 |
Trestolone Acetate (MENT) Raw |
7.5 |
100g |
123.8g |
+23.8% |
96.25% |
Lab A |
| 21 May 2026 |
Trestolone Acetate (MENT) Raw |
7.0 |
100g |
90.2g |
-9.8% |
98.58% |
Lab E |
| 21 May 2026 |
Winstrol Oil (Stanozolol) |
5.8 |
250mg/ml |
265.1mg/ml |
+6.0% |
96.81% |
Lab D |
| 20 May 2026 |
ACE-031 |
9.6 |
30mg |
32.1mg |
+7.1% |
98.81% |
Lab E |
| 20 May 2026 |
Glutathione |
7.9 |
10mg |
8.6mg |
-13.9% |
98.40% |
Lab E |
| 20 May 2026 |
MK-677 (Ibutamoren) Raw |
7.4 |
10g |
10.4g |
+4.5% |
95.52% |
Lab E |
| 20 May 2026 |
NAD+ Injectable |
8.8 |
100mg/ml |
87.3mg/ml |
-12.7% |
95.60% |
Lab A |
| 20 May 2026 |
P21 |
8.3 |
15mg |
13.1mg |
-13.0% |
97.85% |
Lab E |
| 20 May 2026 |
PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 |
6.4 |
500g |
620.9g |
+24.2% |
98.72% |
Lab C |
| 20 May 2026 |
Prostamax |
6.3 |
2mg |
2.2mg |
+9.8% |
99.43% |
Lab A |
| 20 May 2026 |
Telmisartan |
6.5 |
10mg |
8.9mg |
-11.2% |
95.64% |
Lab C |
| 20 May 2026 |
Tesofensine |
6.6 |
20mg |
17.5mg |
-12.5% |
98.24% |
Lab A |
| 20 May 2026 |
Vitamin B12 10mg/ml |
6.3 |
250mg/ml |
269.4mg/ml |
+7.8% |
99.29% |
Lab E |
| 20 May 2026 |
Winstrol Oil (Stanozolol) |
9.7 |
300mg/ml |
327.1mg/ml |
+9.0% |
98.53% |
Lab F |
| 20 May 2026 |
Winstrol Oil (Stanozolol) |
8.1 |
100mg/ml |
93.0mg/ml |
-7.0% |
95.19% |
Lab A |
| 19 May 2026 |
AICAR |
9.2 |
5mg |
5.1mg |
+1.3% |
96.47% |
Lab B |
| 19 May 2026 |
BMK glycidic acid (free acid) CAS 25547-51-7 |
6.0 |
5g |
4.7g |
-6.1% |
97.94% |
Lab B |
| 19 May 2026 |
BPC157 5mg + TB500 5mg Blend |
7.5 |
20mg |
24.1mg |
+20.5% |
99.73% |
Lab E |
| 19 May 2026 |
CJC-1295 With DAC |
7.9 |
30mg |
26.2mg |
-12.5% |
99.15% |
Lab G |
| 19 May 2026 |
Halotestin (Fluoxymesterone) |
8.4 |
50mg |
49.2mg |
-1.7% |
98.06% |
Lab E |
| 19 May 2026 |
HGH Fragment 176-191 |
6.7 |
50mg |
50.5mg |
+0.9% |
97.28% |
Lab F |
| 19 May 2026 |
L-Carnitine 500mg |
6.9 |
200mg/ml |
226.8mg/ml |
+13.4% |
95.85% |
Lab C |
| 19 May 2026 |
MK-677 (Ibutamoren) Raw |
4.0 |
1g |
1.1g |
+7.5% |
96.89% |
Lab E |
| 19 May 2026 |
MOTS-C |
6.8 |
2mg |
2.2mg |
+11.9% |
98.03% |
Lab C |
| 19 May 2026 |
Trestolone Acetate (MENT) Raw |
9.1 |
100g |
100.2g |
+0.2% |
99.71% |
Lab G |
| 19 May 2026 |
Turinabol Raw |
5.7 |
500g |
437.6g |
-12.5% |
99.98% |
Lab A |
| 17 May 2026 |
AICAR |
8.1 |
20mg |
23.4mg |
+17.1% |
98.51% |
Lab G |
| 17 May 2026 |
AICAR |
8.4 |
2mg |
2.0mg |
-1.5% |
97.55% |
Lab B |
| 17 May 2026 |
Dianabol |
8.5 |
100mg |
89.2mg |
-10.8% |
95.04% |
Lab B |
| 17 May 2026 |
Glutathione |
5.7 |
5mg |
4.5mg |
-10.9% |
95.65% |
Lab B |
| 17 May 2026 |
HGH Fragment 176-191 |
6.8 |
5mg |
5.1mg |
+2.6% |
95.89% |
Lab A |
| 17 May 2026 |
Ovagen |
6.8 |
20mg |
17.9mg |
-10.4% |
96.17% |
Lab F |
| 17 May 2026 |
Telmisartan |
6.9 |
25mg |
29.5mg |
+18.2% |
98.12% |
Lab F |
| 17 May 2026 |
Thymosin Alpha-1 |
6.4 |
5mg |
5.3mg |
+6.1% |
96.32% |
Lab E |
| 17 May 2026 |
Turinabol Raw |
5.4 |
5g |
5.9g |
+18.3% |
99.14% |
Lab F |
| 29 Jan 2026 |
BPC157 10mg + TB500 10mg Blend |
6.4 |
10mg |
12.3mg |
+22.6% |
96.48% |
Lab B |
| 29 Jan 2026 |
BPC157 10mg + TB500 10mg Blend |
6.4 |
5mg |
5.1mg |
+2.7% |
96.80% |
Lab A |
| 29 Jan 2026 |
BPC157 10mg + TB500 10mg Blend |
7.5 |
5mg |
4.3mg |
-14.1% |
96.89% |
Lab E |
| 29 Jan 2026 |
BPC157 5mg + TB500 5mg Blend |
6.9 |
20mg |
22.8mg |
+13.9% |
96.33% |
Lab B |
| 29 Jan 2026 |
Enclomiphene |
6.7 |
20mg |
23.0mg |
+15.1% |
95.47% |
Lab G |
| 29 Jan 2026 |
Enclomiphene |
7.7 |
10mg |
8.8mg |
-11.7% |
98.72% |
Lab E |
| 29 Jan 2026 |
Finasteride |
8.7 |
10mg |
10.7mg |
+7.3% |
95.15% |
Lab B |
| 29 Jan 2026 |
Glutathione |
8.5 |
30mg |
29.4mg |
-2.1% |
98.45% |
Lab B |
| 29 Jan 2026 |
L-Carnitine 500mg |
6.3 |
200mg/ml |
222.2mg/ml |
+11.1% |
97.14% |
Lab B |
| 29 Jan 2026 |
Telmisartan |
7.6 |
50mg |
51.9mg |
+3.9% |
95.49% |
Lab E |
| 29 Jan 2026 |
Trestolone Acetate (MENT) Raw |
8.6 |
1g |
0.9g |
-14.4% |
95.45% |
Lab D |
| 26 Jan 2026 |
BMK glycidic acid (free acid) CAS 25547-51-7 |
5.5 |
500g |
556.2g |
+11.2% |
95.43% |
Lab E |
| 26 Jan 2026 |
BPC157 5mg + TB500 5mg Blend |
8.0 |
2mg |
2.3mg |
+15.5% |
96.69% |
Lab E |
| 26 Jan 2026 |
CJC-1295 With DAC |
6.9 |
10mg |
10.0mg |
-0.1% |
98.17% |
Lab B |
| 26 Jan 2026 |
Enclomiphene |
6.0 |
10mg |
8.9mg |
-11.5% |
97.49% |
Lab D |
| 26 Jan 2026 |
L-Carnitine 500mg |
7.6 |
250mg/ml |
308.7mg/ml |
+23.5% |
98.13% |
Lab F |
| 26 Jan 2026 |
MK-677 (Ibutamoren) Raw |
6.2 |
5g |
4.5g |
-9.9% |
99.87% |
Lab D |
| 26 Jan 2026 |
Primobolan Oral (Methenolone Acetate) |
8.0 |
20mg |
23.6mg |
+17.8% |
99.35% |
Lab F |
| 26 Jan 2026 |
Telmisartan |
8.0 |
25mg |
23.8mg |
-4.9% |
95.50% |
Lab D |
| 26 Jan 2026 |
Telmisartan |
5.6 |
10mg |
9.7mg |
-2.6% |
99.91% |
Lab F |
| 26 Jan 2026 |
Telmisartan |
6.5 |
50mg |
60.5mg |
+21.0% |
95.72% |
Lab C |
| 26 Jan 2026 |
Telmisartan |
8.9 |
50mg |
43.8mg |
-12.5% |
97.46% |
Lab F |
| 26 Jan 2026 |
Winstrol Oil (Stanozolol) |
7.2 |
200mg/ml |
170.0mg/ml |
-15.0% |
96.81% |
Lab B |
| 19 Jan 2026 |
BMK glycidic acid (free acid) CAS 25547-51-7 |
7.1 |
100g |
98.2g |
-1.8% |
99.94% |
Lab B |
| 19 Jan 2026 |
BPC157 10mg + TB500 10mg Blend |
7.9 |
50mg |
56.0mg |
+11.9% |
97.60% |
Lab G |
| 19 Jan 2026 |
CJC-1295 With DAC |
4.3 |
20mg |
21.9mg |
+9.5% |
97.90% |
Lab A |
| 19 Jan 2026 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
6.5 |
20mg |
23.6mg |
+17.9% |
97.00% |
Lab B |
| 19 Jan 2026 |
Enclomiphene |
7.5 |
25mg |
21.7mg |
-13.4% |
95.03% |
Lab C |
| 19 Jan 2026 |
Halotestin (Fluoxymesterone) |
6.8 |
50mg |
46.9mg |
-6.2% |
96.91% |
Lab A |
| 19 Jan 2026 |
NAD+ Injectable |
5.6 |
100mg/ml |
93.6mg/ml |
-6.4% |
99.01% |
Lab B |
| 19 Jan 2026 |
Winstrol Oil (Stanozolol) |
6.1 |
100mg/ml |
119.2mg/ml |
+19.2% |
97.14% |
Lab C |
| 19 Jan 2026 |
Winstrol Oil (Stanozolol) |
5.7 |
300mg/ml |
258.2mg/ml |
-13.9% |
96.41% |
Lab C |
| 9 Jan 2026 |
Dianabol |
6.6 |
10mg |
9.2mg |
-8.4% |
98.64% |
Lab C |
| 9 Jan 2026 |
Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) |
8.8 |
100mg/ml |
113.8mg/ml |
+13.8% |
98.50% |
Lab D |
| 9 Jan 2026 |
Primobolan Oral (Methenolone Acetate) |
6.7 |
50mg |
59.0mg |
+18.1% |
97.66% |
Lab G |
| 9 Jan 2026 |
Prostamax |
7.5 |
5mg |
5.9mg |
+18.8% |
99.30% |
Lab C |
| 7 Jan 2026 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
6.2 |
10mg |
11.2mg |
+11.7% |
95.56% |
Lab A |
| 7 Jan 2026 |
Finasteride |
5.0 |
25mg |
28.3mg |
+13.1% |
96.62% |
Lab A |
| 7 Jan 2026 |
Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) |
5.1 |
100mg/ml |
117.9mg/ml |
+17.9% |
96.66% |
Lab D |
| 7 Jan 2026 |
L-Carnitine 500mg |
6.8 |
300mg/ml |
344.5mg/ml |
+14.8% |
95.50% |
Lab G |
| 7 Jan 2026 |
L-Carnitine 500mg |
6.6 |
100mg/ml |
122.8mg/ml |
+22.8% |
97.95% |
Lab G |
| 7 Jan 2026 |
Lipo-C FAT BLASTER |
6.7 |
300mg/ml |
264.6mg/ml |
-11.8% |
98.41% |
Lab E |
| 7 Jan 2026 |
MK-677 (Ibutamoren) Raw |
4.2 |
100g |
92.5g |
-7.5% |
96.64% |
Lab G |
| 7 Jan 2026 |
NAD+ Injectable |
8.3 |
200mg/ml |
174.8mg/ml |
-12.6% |
97.95% |
Lab D |
| 7 Jan 2026 |
PE 22-28 |
7.0 |
2mg |
1.9mg |
-2.7% |
95.20% |
Lab D |
| 7 Jan 2026 |
PE 22-28 |
5.7 |
5mg |
5.7mg |
+13.6% |
95.43% |
Lab A |
| 7 Jan 2026 |
Primobolan Oral (Methenolone Acetate) |
6.1 |
10mg |
12.4mg |
+24.0% |
95.66% |
Lab E |
| 7 Jan 2026 |
Trestolone Acetate (MENT) Raw |
6.3 |
100g |
117.7g |
+17.7% |
99.76% |
Lab F |
| 6 Jan 2026 |
ACE-031 |
8.7 |
10mg |
9.0mg |
-10.2% |
96.63% |
Lab E |
| 6 Jan 2026 |
ACE-031 |
7.9 |
50mg |
45.1mg |
-9.9% |
95.93% |
Lab F |
| 6 Jan 2026 |
BPC157 5mg + TB500 5mg Blend |
4.9 |
20mg |
19.2mg |
-3.9% |
99.43% |
Lab E |
| 6 Jan 2026 |
HGH Fragment 176-191 |
7.4 |
10mg |
10.8mg |
+8.1% |
96.94% |
Lab A |
| 6 Jan 2026 |
NAD+ Injectable |
9.3 |
300mg/ml |
330.0mg/ml |
+10.0% |
98.17% |
Lab E |
| 6 Jan 2026 |
PE 22-28 |
6.5 |
20mg |
18.3mg |
-8.4% |
96.36% |
Lab B |
| 6 Jan 2026 |
Telmisartan |
6.3 |
100mg |
92.8mg |
-7.2% |
96.19% |
Lab B |
| 29 Dec 2025 |
Enclomiphene |
8.2 |
50mg |
51.8mg |
+3.7% |
97.84% |
Lab G |
| 29 Dec 2025 |
Finasteride |
5.8 |
25mg |
30.1mg |
+20.2% |
98.24% |
Lab B |
| 29 Dec 2025 |
GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg |
6.8 |
20mg |
20.7mg |
+3.7% |
96.48% |
Lab G |
| 29 Dec 2025 |
Halotestin (Fluoxymesterone) |
7.8 |
25mg |
26.1mg |
+4.6% |
99.85% |
Lab B |
| 29 Dec 2025 |
HGH Fragment 176-191 |
8.1 |
2mg |
2.1mg |
+4.7% |
99.67% |
Lab C |
| 29 Dec 2025 |
Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) |
6.8 |
100mg/ml |
95.3mg/ml |
-4.7% |
97.69% |
Lab B |
| 29 Dec 2025 |
MK-677 (Ibutamoren) Raw |
7.9 |
100g |
107.9g |
+7.9% |
98.93% |
Lab B |
| 29 Dec 2025 |
MOTS-C |
6.7 |
10mg |
9.2mg |
-8.1% |
98.45% |
Lab E |
| 29 Dec 2025 |
PE 22-28 |
8.5 |
50mg |
43.7mg |
-12.7% |
95.83% |
Lab B |
| 29 Dec 2025 |
PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 |
8.0 |
10g |
11.7g |
+17.0% |
99.36% |
Lab F |
| 29 Dec 2025 |
PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 |
6.1 |
5g |
4.5g |
-9.3% |
99.14% |
Lab E |
| 29 Dec 2025 |
Tesofensine |
7.5 |
25mg |
30.9mg |
+23.7% |
96.53% |
Lab B |
| 29 Dec 2025 |
Trestolone Acetate (MENT) Raw |
5.0 |
5g |
5.3g |
+5.6% |
95.15% |
Lab A |
| 12 Dec 2025 |
ACE-031 |
8.3 |
50mg |
61.9mg |
+23.7% |
97.71% |
Lab B |
| 12 Dec 2025 |
BMK glycidic acid (free acid) CAS 25547-51-7 |
6.5 |
10g |
11.2g |
+11.9% |
98.65% |
Lab F |
| 12 Dec 2025 |
BPC157 5mg + TB500 5mg Blend |
8.2 |
20mg |
22.3mg |
+11.7% |
99.71% |
Lab C |
| 12 Dec 2025 |
CJC-1295 With DAC |
6.3 |
5mg |
4.9mg |
-2.1% |
98.72% |
Lab E |
| 12 Dec 2025 |
Enclomiphene |
4.9 |
20mg |
22.1mg |
+10.7% |
99.41% |
Lab B |
| 12 Dec 2025 |
Enclomiphene |
6.3 |
50mg |
51.8mg |
+3.5% |
97.60% |
Lab F |
| 12 Dec 2025 |
Finasteride |
7.5 |
50mg |
50.5mg |
+1.0% |
98.82% |
Lab F |
| 12 Dec 2025 |
Lipo-C FAT BLASTER |
8.6 |
100mg/ml |
91.7mg/ml |
-8.3% |
99.68% |
Lab C |
| 12 Dec 2025 |
Methylene Blue |
7.2 |
25mg |
27.4mg |
+9.5% |
95.16% |
Lab D |
| 12 Dec 2025 |
MK-677 (Ibutamoren) Raw |
4.3 |
500g |
467.0g |
-6.6% |
95.38% |
Lab C |
| 12 Dec 2025 |
MOTS-C |
6.0 |
5mg |
5.0mg |
-0.7% |
95.02% |
Lab E |
| 12 Dec 2025 |
NAD+ Injectable |
4.3 |
300mg/ml |
343.3mg/ml |
+14.4% |
97.63% |
Lab D |
| 12 Dec 2025 |
PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 |
6.3 |
5g |
5.1g |
+3.0% |
97.92% |
Lab A |
| 12 Dec 2025 |
Thymosin Alpha-1 |
7.7 |
20mg |
24.8mg |
+23.8% |
98.93% |
Lab F |
| 5 Dec 2025 |
BMK glycidic acid (free acid) CAS 25547-51-7 |
7.5 |
5g |
5.3g |
+5.8% |
97.22% |
Lab F |
| 5 Dec 2025 |
Glutathione |
7.1 |
5mg |
5.3mg |
+6.4% |
99.34% |
Lab C |
| 5 Dec 2025 |
MOTS-C |
8.8 |
20mg |
23.0mg |
+14.9% |
96.42% |
Lab F |
| 5 Dec 2025 |
MOTS-C |
7.3 |
50mg |
50.1mg |
+0.2% |
99.50% |
Lab B |
| 5 Dec 2025 |
Ovagen |
5.6 |
2mg |
2.4mg |
+21.7% |
96.33% |
Lab D |
| 5 Dec 2025 |
PE 22-28 |
7.3 |
30mg |
33.5mg |
+11.8% |
97.16% |
Lab F |
| 5 Dec 2025 |
Winstrol Oil (Stanozolol) |
5.9 |
300mg/ml |
310.3mg/ml |
+3.4% |
97.39% |
Lab F |
| 23 Nov 2025 |
BPC157 5mg + TB500 5mg Blend |
4.8 |
50mg |
47.1mg |
-5.8% |
96.08% |
Lab E |
| 23 Nov 2025 |
CJC-1295 With DAC |
5.9 |
5mg |
4.9mg |
-2.4% |
96.44% |
Lab F |
| 23 Nov 2025 |
Lipo-C FAT BLASTER |
6.9 |
300mg/ml |
353.3mg/ml |
+17.8% |
98.53% |
Lab C |
| 23 Nov 2025 |
MOTS-C |
7.0 |
15mg |
16.2mg |
+8.1% |
96.72% |
Lab C |
| 23 Nov 2025 |
Ovagen |
6.8 |
50mg |
59.6mg |
+19.1% |
99.78% |
Lab G |
| 23 Nov 2025 |
PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 |
6.7 |
500g |
513.8g |
+2.8% |
97.81% |
Lab E |
| 23 Nov 2025 |
Tesofensine |
5.7 |
10mg |
8.8mg |
-12.0% |
96.05% |
Lab E |
| 23 Nov 2025 |
Winstrol Oil (Stanozolol) |
5.7 |
250mg/ml |
220.0mg/ml |
-12.0% |
98.33% |
Lab A |
| 17 Nov 2025 |
ACE-031 |
7.2 |
15mg |
16.2mg |
+8.0% |
99.05% |
Lab B |
| 17 Nov 2025 |
BPC157 5mg + TB500 5mg Blend |
6.6 |
5mg |
4.4mg |
-11.3% |
99.15% |
Lab E |
| 17 Nov 2025 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
7.7 |
30mg |
29.4mg |
-2.1% |
97.68% |
Lab G |
| 17 Nov 2025 |
Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) |
9.2 |
300mg/ml |
342.8mg/ml |
+14.3% |
96.99% |
Lab D |
| 17 Nov 2025 |
Lipo-C FAT BLASTER |
6.8 |
300mg/ml |
320.5mg/ml |
+6.8% |
97.65% |
Lab D |
| 17 Nov 2025 |
SLU-PP-332 250mcg + BAM15 50mcg Blend |
4.0 |
20mg |
20.6mg |
+2.9% |
99.33% |
Lab D |
| 17 Nov 2025 |
Trestolone Acetate (MENT) Raw |
5.8 |
1g |
1.1g |
+5.4% |
98.41% |
Lab G |
| 14 Nov 2025 |
BMK glycidic acid (free acid) CAS 25547-51-7 |
8.0 |
500g |
533.4g |
+6.7% |
97.58% |
Lab E |
| 14 Nov 2025 |
BPC157 10mg + TB500 10mg Blend |
6.5 |
2mg |
2.3mg |
+15.4% |
97.49% |
Lab A |
| 14 Nov 2025 |
BPC157 10mg + TB500 10mg Blend |
6.1 |
10mg |
8.8mg |
-11.7% |
98.12% |
Lab D |
| 14 Nov 2025 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
9.3 |
30mg |
33.5mg |
+11.8% |
99.47% |
Lab B |
| 14 Nov 2025 |
Enclomiphene |
7.9 |
50mg |
57.3mg |
+14.5% |
98.19% |
Lab E |
| 14 Nov 2025 |
Finasteride |
5.9 |
25mg |
21.4mg |
-14.3% |
95.93% |
Lab A |
| 14 Nov 2025 |
GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg |
6.2 |
5mg |
5.6mg |
+11.3% |
95.97% |
Lab D |
| 14 Nov 2025 |
HGH Fragment 176-191 |
6.0 |
30mg |
35.0mg |
+16.6% |
99.55% |
Lab G |
| 14 Nov 2025 |
Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) |
9.7 |
100mg/ml |
112.5mg/ml |
+12.5% |
95.83% |
Lab E |
| 14 Nov 2025 |
L-Carnitine 500mg |
5.9 |
100mg/ml |
102.0mg/ml |
+2.0% |
95.87% |
Lab B |
| 14 Nov 2025 |
L-Carnitine 500mg |
5.5 |
200mg/ml |
176.3mg/ml |
-11.9% |
99.32% |
Lab B |
| 14 Nov 2025 |
Ovagen |
6.6 |
20mg |
17.5mg |
-12.6% |
96.88% |
Lab G |
| 14 Nov 2025 |
P21 |
6.6 |
2mg |
1.7mg |
-12.6% |
98.12% |
Lab B |
| 14 Nov 2025 |
PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 |
7.2 |
500g |
428.1g |
-14.4% |
99.84% |
Lab G |
| 14 Nov 2025 |
Primobolan Oral (Methenolone Acetate) |
8.1 |
10mg |
10.8mg |
+7.6% |
96.36% |
Lab B |
| 14 Nov 2025 |
Primobolan Oral (Methenolone Acetate) |
6.6 |
50mg |
48.7mg |
-2.6% |
97.86% |
Lab E |
| 14 Nov 2025 |
Turinabol Raw |
8.9 |
1g |
1.0g |
+4.8% |
99.13% |
Lab E |
| 5 Nov 2025 |
ACE-031 |
6.2 |
50mg |
48.8mg |
-2.4% |
96.46% |
Lab G |
| 5 Nov 2025 |
BMK glycidic acid (free acid) CAS 25547-51-7 |
5.4 |
500g |
580.3g |
+16.1% |
97.39% |
Lab F |
| 5 Nov 2025 |
BPC157 5mg + TB500 5mg Blend |
7.1 |
30mg |
28.5mg |
-5.1% |
95.81% |
Lab E |
| 5 Nov 2025 |
Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) |
8.4 |
200mg/ml |
215.4mg/ml |
+7.7% |
98.41% |
Lab D |
| 5 Nov 2025 |
MK-677 (Ibutamoren) Raw |
4.9 |
500g |
435.4g |
-12.9% |
99.71% |
Lab F |
| 5 Nov 2025 |
MOTS-C |
7.4 |
50mg |
48.0mg |
-4.0% |
98.00% |
Lab B |
| 5 Nov 2025 |
PE 22-28 |
8.8 |
5mg |
4.5mg |
-10.7% |
98.01% |
Lab A |
| 5 Nov 2025 |
PE 22-28 |
8.0 |
30mg |
36.1mg |
+20.3% |
95.69% |
Lab B |
| 5 Nov 2025 |
PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 |
6.7 |
10g |
10.2g |
+2.1% |
96.86% |
Lab D |
| 5 Nov 2025 |
Turinabol Raw |
6.6 |
10g |
10.7g |
+6.7% |
95.46% |
Lab F |
| 5 Nov 2025 |
Winstrol Oil (Stanozolol) |
8.3 |
300mg/ml |
300.5mg/ml |
+0.2% |
97.18% |
Lab D |
| 4 Nov 2025 |
ACE-031 |
8.0 |
5mg |
4.8mg |
-3.9% |
97.36% |
Lab C |
| 4 Nov 2025 |
Halotestin (Fluoxymesterone) |
7.1 |
25mg |
28.1mg |
+12.4% |
96.19% |
Lab C |
| 4 Nov 2025 |
Lipo-C FAT BLASTER |
6.6 |
300mg/ml |
357.4mg/ml |
+19.1% |
96.91% |
Lab F |
| 4 Nov 2025 |
MK-677 (Ibutamoren) Raw |
7.5 |
500g |
528.7g |
+5.7% |
97.38% |
Lab C |
| 4 Nov 2025 |
Ovagen |
8.7 |
15mg |
16.4mg |
+9.2% |
99.30% |
Lab G |
| 4 Nov 2025 |
PE 22-28 |
10.0 |
50mg |
60.7mg |
+21.3% |
99.63% |
Lab E |
| 4 Nov 2025 |
PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 |
4.6 |
10g |
11.7g |
+17.4% |
95.92% |
Lab C |
| 4 Nov 2025 |
Trestolone Acetate (MENT) Raw |
7.2 |
500g |
503.0g |
+0.6% |
97.17% |
Lab D |
| 17 Oct 2025 |
ACE-031 |
5.9 |
15mg |
16.2mg |
+8.3% |
96.06% |
Lab B |
| 17 Oct 2025 |
BMK glycidic acid (free acid) CAS 25547-51-7 |
7.4 |
100g |
123.0g |
+23.0% |
96.77% |
Lab F |
| 17 Oct 2025 |
BPC157 5mg + TB500 5mg Blend |
7.7 |
5mg |
5.8mg |
+16.9% |
96.53% |
Lab F |
| 17 Oct 2025 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
6.1 |
20mg |
23.1mg |
+15.3% |
95.30% |
Lab D |
| 17 Oct 2025 |
Glutathione |
7.2 |
10mg |
11.6mg |
+15.6% |
97.98% |
Lab E |
| 17 Oct 2025 |
Glutathione |
7.7 |
10mg |
11.4mg |
+14.0% |
98.76% |
Lab G |
| 17 Oct 2025 |
Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) |
8.7 |
100mg/ml |
117.3mg/ml |
+17.3% |
97.94% |
Lab B |
| 17 Oct 2025 |
NAD+ Injectable |
6.6 |
200mg/ml |
201.7mg/ml |
+0.9% |
99.47% |
Lab A |
| 17 Oct 2025 |
Ovagen |
5.7 |
2mg |
1.9mg |
-7.0% |
95.57% |
Lab F |
| 17 Oct 2025 |
Telmisartan |
7.0 |
10mg |
12.5mg |
+24.7% |
99.53% |
Lab F |
| 17 Oct 2025 |
Winstrol Oil (Stanozolol) |
6.0 |
100mg/ml |
114.4mg/ml |
+14.4% |
95.03% |
Lab D |
| 9 Oct 2025 |
BPC157 10mg + TB500 10mg Blend |
5.8 |
2mg |
2.3mg |
+16.5% |
97.61% |
Lab D |
| 9 Oct 2025 |
Methylene Blue |
4.9 |
100mg |
97.3mg |
-2.7% |
97.67% |
Lab G |
| 9 Oct 2025 |
PE 22-28 |
8.4 |
2mg |
2.5mg |
+24.0% |
96.74% |
Lab E |
| 9 Oct 2025 |
Prostamax |
7.3 |
30mg |
36.6mg |
+21.9% |
97.97% |
Lab G |
| 9 Oct 2025 |
Telmisartan |
8.3 |
50mg |
51.8mg |
+3.6% |
98.38% |
Lab D |
| 9 Oct 2025 |
Winstrol Oil (Stanozolol) |
7.1 |
250mg/ml |
299.9mg/ml |
+20.0% |
96.00% |
Lab B |
| 3 Oct 2025 |
BPC157 5mg + TB500 5mg Blend |
6.2 |
2mg |
2.2mg |
+11.5% |
98.82% |
Lab F |
| 3 Oct 2025 |
Glutathione |
6.8 |
50mg |
49.6mg |
-0.7% |
97.94% |
Lab G |
| 3 Oct 2025 |
L-Carnitine 500mg |
4.8 |
200mg/ml |
242.3mg/ml |
+21.1% |
97.54% |
Lab E |
| 3 Oct 2025 |
Methylene Blue |
9.9 |
10mg |
9.3mg |
-6.9% |
96.67% |
Lab E |
| 3 Oct 2025 |
MK-677 (Ibutamoren) Raw |
4.0 |
1g |
1.1g |
+6.8% |
96.70% |
Lab B |
| 3 Oct 2025 |
PE 22-28 |
9.3 |
5mg |
6.2mg |
+23.9% |
97.40% |
Lab C |
| 3 Oct 2025 |
Pinealon |
5.7 |
5mg |
5.4mg |
+8.6% |
97.81% |
Lab C |